Introduction
Vascular tumors of the head and neck are abnormal growths that originate from blood vessels or lymphatic vessels. They are of two types such as benign and malignant. The most common benign vascular tumors are hemangiomas. Symptoms of tumors are swelling, discoloration, and pain, and rarely there are breathing or swallowing difficulties.
Why Can Vascular Tumors in the Head and Neck Be Life-Threatening?
Vascularized tumors are primarily benign tumors that arise from the superficial epithelium or the skin surface of affected individuals, including newborns with various genetic conditions. These tumors can potentially affect internal organs such as the liver, gastrointestinal system, larynx, or even the lungs. In terms of the oral cavity, hemangiomas typically occur in regions such as the buccal mucosa, gingiva, palatal mucosa, salivary glands, tongue, lips, alveolar ridge, or jaw bones.
Vascular benign tumors, or hemangiomas, occurring in the orofacial regions or the head and neck can cause multiple complications in the human body. These complications can range from sudden respiratory distress and feeding difficulties in infants or young children to issues with the normal coagulation cascade, which may alter bleeding and clotting pathways. Hemangiomas can negatively affect vision, initiate systemic infections, and serve as a source of ear infections or even hearing deficiencies and congenital ear issues. These functional discrepancies can lead to potentially life-threatening complications in affected patients due to vascular hemangiomas in the head and neck, especially given the high risk of ulceration, facial disfigurement, and issues with orofacial functions, along with a clear association with underlying structural defects or congenital syndromes.
How Are Vascular Tumors of the Head and Neck Managed?
Let us explore some of the traditional and new-age treatment modalities for vascular tumors or hemangiomas located in the head and neck. Among the therapeutic interventions that have been practiced for many decades, corticosteroid therapy has proven to be particularly effective in the management of vascular tumors.
A. Oral Propranolol:
This agent has been demonstrated as per documented case reports to be very effective in the management of newborn or infantile hemangiomas. While there are certain side effects just like other oral drugs, it is generally shown to be well tolerated in infants. Also, the side effects are quite minimal, and in general management of small to moderate hemangiomas, Propranolol administration can prove beneficial.
B. Intra-Tumoral Ligation, Surgical Resection, Along With Laser Therapy or Sclerotherapy:
While surgical excision is certainly an option considered for most adult patients, it is a more invasive approach for extensive hemangiomas in children or young adolescents. This procedure is typically performed to prevent the recurrence of benign tumors and to effectively eliminate tumor margins, especially when combined with adjunct therapies such as laser therapy or sclerotherapy, which are newer treatment modalities.
In adult patients, intra-tumoral ligation, whether used as an isolated approach or in combination with laser therapy or sclerotherapy—remains the most preferred therapeutic method for adult hemangiomas. For similar vascular lesions or tumors that resemble hemangiomas, oral surgeons commonly perform surgical resection along with the use of laser therapy or sclerotherapy. Laser surgery has emerged as one of the revolutionary technologies that can be effectively utilized for postoperative healing and in controlling symptoms such as postoperative pain and swelling, which are common complications.
During the early 1980s, lasers such as argon and carbon dioxide were primarily used on a preliminary basis for excising capillary or cavernous hemangiomas of the head and neck. Today, modern lasers are also utilized to control postoperative bleeding and achieve effective wound healing.
C. Superficial Cryotherapy With Carbon Dioxide Snow:
This would be an effective method only for small-sized vascular hemangiomas of the head and neck, especially in the conservative treatment of facial hemangioma. This procedure is however not surgically recommended for excising tuberous or cavernous hemangiomas that are of deep origin and more penetrance.
D. Conservative Corticosteroid Therapies:
This can be through two modalities- either the use of systemic medications like Prednisone for vascular hemangioma dissolution or through local corticosteroid therapy such as Triamcinolone acetonide. In perspective to small or medium-sized hemangiomas of the head and neck, in tune with the conservative protocols recommended by maxillofacial surgeons, corticosteroid therapy in fact remains one of the mainline strategies for the elimination of hemangiomas. But whether in newborns or in your children, the dosage and the side effects need to be considered cautiously by the surgeon, as there would be a high risk of growth stunting and growth malformations in children with the repeated use of local as well as systemic corticosteroids.
Prednisone administered in a daily dose of around usually 2 to 4 mg/kg weight of the body is the conservative therapeutic strategy for curing cutaneous infantile head and neck hemangiomas. Parotid hemangiomas however are a classic example that can be resistant to conservative therapies and may require excision.
Systemic corticosteroids like Prednisone are commonly used by surgeons in children and young adolescents alike for managing large or aggressive hemangioma head and neck lesions.
Local corticosteroids are usually administered in the form of intralesional corticosteroid injections that are aimed specifically at managing smaller-sized facial hemangiomas. The local corticosteroid dose recommended by physicians for managing orofacial hemangiomas is approximately 20mg/ml in the form of Triamcinolone acetonide, administered at around six to eight-week intervals, with approximately three to five injection doses needed. It is important for the maxillofacial surgeon or physician to keep the affected local and surrounding areas compressed during the administration of corticosteroid therapy. Contraindications for local corticosteroids are clinical symptoms in patients affected such as primary cell necrosis or any secondary infection of the hemangioma lesions, where these agents are contraindicated. Local corticosteroid use is also limited in eye hemangiomas generally, due to increased side effect risk.
E. Interferon Therapies:
Interferon alpha 1 or interferon alpha 2 are common new-age drug therapies used for managing vascular tumors with a daily dose of around 3 million U/m2 (unified atomic mass unit/ meter administered as a subcutaneous injection form. These drugs are basically aimed at eliminating vascular benign tumors or malformations arising from the target pre-existing blood vessels that have scope for aggravation or spread further - and so do not typically respond to corticosteroid therapies. However, they are associated with several side effects ranging from hepatoportal issues or have long-term neurotoxicity concerns with repeated administrations for such tumors, as per current research, requiring more detail and investigation into their therapeutic benefits for vascular tumors.
Conclusion:
The various outline measures adopted by maxillofacial or oncologic surgeons for eliminating vascular tumors of the head and neck are complex and have their fair share of advantages and side effects. New age modalities including conservative corticosteroid therapies, and advanced laser therapies alongside surgical excision for large vascular tumors hold a promising role in improving the functional efficiency in the jaw region /or in the head and neck regions affected.
